A major pharmaceutical company ended price hikes and monopoly protection over a life-saving asthma inhaler following two years of pressure from U.S. Sen. Maggie Hassan, D-N.H. Without warning in ...
Maggie Hassan. The setup forced many users to pay higher prices and allowed the British drugmaker to avoid paying Medicaid rebates, the report says.
The global pulmonary drug delivery technology market is projected to grow at a CAGR of approximately 5% over the next five years. This growth is driven by the rising prevalence of respiratory diseases ...
The Well News on MSN
EPA seeking to curb restrictions on cancer-linked ethylene oxide
WASHINGTON - The Environmental Protection Agency wants to loosen Biden-era limits on the manufacturing-related release of ethylene oxide, a potent carcinogen that has been linked to increased rates of ...
We look forward to presenting important new data for Afrezza at this year’s ATTD and contributing to the scientific dialogue around meal-time diabetes management across both adult and pediatric ...
Hosted on MSN
Most air cleaning devices have not been tested on people − and little is known about their potential harms
(The Conversation) – Portable air cleaners aimed at curbing indoor spread of infections are rarely tested for how well they protect people – and very few studies evaluate their potentially harmful ...
6d
MannKind Corporation (MNKD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Barclays 28th Annual Global Healthcare Conference March 11, 2026 1:00 PM EDTCompany ParticipantsMichael Castagna - CEO ...
EdgeOne Medical, an integrated development partner for drug-device combination products, today announced that Lee Leichter, a ...
HighlightsAgreement builds on existing Chiesi-Bespak collaboration, reinforcing a trusted relationship as Chiesi works to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results